DRD2 and Hallucinations: Second, in regards to the patients with schizophrenia, increased dopamine in the nigra-striatal pathway is considered to be a driving force of psychosis [66, 67], and the effectiveness of antipsychotics that block the dopamine D2 receptor in relieving hallucinations and delusions is well established [68].